A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer

A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer

Abstract Background Despite being a potentially attractive alternative molecular imaging modality due to wider availability and association with lethal disease in advanced prostate cancer, the role of fluorodeoxyglucose (FDG)- positron emission tomography (PET) at initial diagnosis compared to Prost...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthew J. Roberts, Natasha A. Roberts, Anita Pelecanos, John W. Yaxley, Simon J. D. Harley, Amila R. Siriwardana, Karla Cullen, Marita Prior, Karen Lindsay, Ian Vela, Anna Kuchel, Nattakorn Dhiantravan, Paul Thomas, David A. Pattison
Format: Article
Language:English
Published: SpringerOpen 2025-07-01
Series:EJNMMI Research
Subjects:
Prostate cancer
Prostate-specific membrane antigen
PSMA
PET/CT
18F-FDG
Cancer staging
Online Access:https://doi.org/10.1186/s13550-025-01265-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13550-025-01265-z

Similar Items